First Detection of Carbapenem-Resistant Strains Harbouring Beta-Lactamase Genes from Clinical Samples.

Recently discovered extraintestinal obtained from non-clinical samples has exhibited the potential for acquiring multiple beta-lactamase genes, just like many extraintestinal strains. Albeit, they are often omitted or classified as . This study aimed to, therefore, identify carbapenem-resistant extended-spectrum beta-lactamase (ESBL) producing isolates from clinical samples, determine their evolutionary relatedness using 16S rRNA sequencing analysis and screen for beta-lactamase genes.